Ordaos

New York, NY · Founded 2019 · Privately Held (backing)

Operator of a human-enabled machine-driven drug design company intended for biomedical research and drug discovery. Ordaos is based in New York, NY and was founded in 2019. Its last reported valuation was $110 million in Nov 2024. It has raised $24.5 million across 6 recorded rounds; the latest was a $337,705 seed round in Feb 2025.

Last reported valuation
$110.0M
Oct 2026
Priced at
—
Total raised
$24.5M
Last round
Seed Round
Feb 2025
Cap table — not yet on record

Ordaos's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ordaos with a free account
  • ·The complete investor list: 16 names
  • ·Watch Ordaos: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Ordaos

Where does Ordaos's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ordaos's 6 recorded funding rounds.